JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS - Journal - Bridge of Knowledge

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

ISSN:

0022-3565

eISSN:

1521-0103

Disciplines
(Field of Science):

biomedical engineering (Engineering and Technology)
medical biology (Medical and Health Sciences )
pharmacology and pharmacy (Medical and Health Sciences )
medical sciences (Medical and Health Sciences )
health sciences (Medical and Health Sciences )
food and nutrition technology (Agricultural sciences)
biotechnology (Natural sciences)
biological sciences (Natural sciences)
chemical sciences (Natural sciences)

expand collapse

Ministry points: Help

Ministry points - current year
Year	Points	List
Year 2024	140	Ministry scored journals list 2024

expand collapse

Ministry points - previous years
Year	Points	List
2024	140	Ministry scored journals list 2024
2023	140	Ministry Scored Journals List
2022	140	Ministry Scored Journals List 2019-2022
2021	140	Ministry Scored Journals List 2019-2022
2020	140	Ministry Scored Journals List 2019-2022
2019	140	Ministry Scored Journals List 2019-2022
2018	35	A
2017	35	A
2016	35	A
2015	35	A
2014	35	A
2013	35	A
2012	35	A
2011	35	A
2010	32	A

Model:

Hybrid

Points CiteScore:

Points CiteScore - current year
Year	Points
Year 2023	6.9

expand collapse

Points CiteScore - previous years
Year	Points
2023	6.9
2022	8.4
2021	7.1
2020	6.4
2019	5.9
2018	6.8
2017	7.4
2016	7.5
2015	8.3
2014	8.3
2013	8.3
2012	7.8
2011	7.7

Impact Factor:

Log in to see the Impact Factor.

Sherpa Romeo:

https://v2.sherpa.ac.uk/id/publication/9890

Papers published in journal

results on page:
year:
- selected sort by year newest first
- sort by year oldest first
title:
- selected sort by title A-Z
- sort by title Z-A
citation:
- sort by citation descending
- sort by citation ascending

Filters

total: 1

Year 2013

DNA-damaging imidazoacridinone C-1311 induces autophagy followed by irreversible growth arrest and senescence in human lung cancer cells
Publication
- J. Polewska
- A. Skwarska
- E. Augustin
- J. Konopa
- JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS - Year 2013
Imidazoacridinone 5-diethylaminoethylamino-8-hydroxyimidazoacridinone (C-1311) is an antitumor inhibitor of topoisomerase II and FMS-like tyrosine kinase 3 receptor. In this study, we describe the unique sequence of cellular responses to C-1311 in human non-small cell lung cancer (NSCLC) cell lines, A549 and H460. In A549 cells, C-1311 (IC80 = 0.08 µM) induced G1 and G2/M arrests, whereas H460 cells (IC80 = 0.051 µM) accumulated...

Full text to download in external service

seen 641 times